Vanda Pharmaceuticals (VNDA) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.18% |
| Dec 31, 2025 | -11.48% |
| Sep 30, 2025 | -8.90% |
| Jun 30, 2025 | -8.36% |
| Mar 31, 2025 | -8.85% |
| Dec 31, 2024 | -11.21% |
| Sep 30, 2024 | -12.12% |
| Jun 30, 2024 | -11.49% |
| Mar 31, 2024 | -11.69% |
| Dec 31, 2023 | -14.34% |
| Sep 30, 2023 | -14.21% |
| Jun 30, 2023 | -14.73% |
| Mar 31, 2023 | -14.50% |
| Dec 31, 2022 | -13.48% |
| Sep 30, 2022 | -13.79% |
| Jun 30, 2022 | -13.62% |
| Mar 31, 2022 | -11.79% |
| Dec 31, 2021 | -9.10% |
| Sep 30, 2021 | -6.85% |
| Jun 30, 2021 | -3.08% |
| Mar 31, 2021 | -2.47% |
| Dec 31, 2020 | -1.98% |
| Sep 30, 2020 | -1.17% |
| Jun 30, 2020 | -0.65% |
| Mar 31, 2020 | 4.71% |
| Dec 31, 2019 | 9.66% |
| Sep 30, 2019 | 13.23% |
| Jun 30, 2019 | 12.90% |
| Mar 31, 2019 | 14.23% |
| Dec 31, 2018 | 14.98% |
| Sep 30, 2018 | 16.81% |
| Jun 30, 2018 | 16.80% |
| Mar 31, 2018 | 17.66% |
| Dec 31, 2017 | 17.71% |
| Sep 30, 2017 | 17.37% |
| Jun 30, 2017 | 17.65% |
| Mar 31, 2017 | 17.12% |
| Dec 31, 2016 | 39.07% |
| Sep 30, 2016 | 40.93% |
| Jun 30, 2016 | 34.55% |
| Dec 31, 2015 | 37.29% |